Cargando…
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group
IMPORTANCE: Gastrointestinal stromal tumor (GIST) follow-up is recommended by international guidelines, but data on the role of follow-up in patients with low relapse risk are missing. For these patients, the potential benefit of anticipating recurrence detection should be weighed against psychologi...
Autores principales: | D’Ambrosio, Lorenzo, Fumagalli, Elena, De Pas, Tommaso Martino, Nannini, Margherita, Bertuzzi, Alexia, Carpano, Silvia, Boglione, Antonella, Buonadonna, Angela, Comandini, Danila, Gasperoni, Silvia, Vincenzi, Bruno, Brunello, Antonella, Badalamenti, Giuseppe, Maccaroni, Elena, Baldi, Giacomo Giulio, Merlini, Alessandra, Mogavero, Andrea, Ligorio, Francesca, Pennacchioli, Elisabetta, Conforti, Fabio, Manessi, Giulia, Aliberti, Sandra, Tolomeo, Francesco, Fiore, Marco, Sbaraglia, Marta, Dei Tos, Angelo Paolo, Stacchiotti, Silvia, Pantaleo, Maria Abbondanza, Gronchi, Alessandro, Grignani, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628737/ https://www.ncbi.nlm.nih.gov/pubmed/37930700 http://dx.doi.org/10.1001/jamanetworkopen.2023.41522 |
Ejemplares similares
-
Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions
por: Merlini, Alessandra, et al.
Publicado: (2023) -
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study
por: Nannini, M., et al.
Publicado: (2021) -
Familial adenomatosis polyposis–related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
por: Napolitano, Andrea, et al.
Publicado: (2020) -
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers
por: Zagami, Paola, et al.
Publicado: (2023) -
Imatinib rechallenge in patients with advanced gastrointestinal
stromal tumors following progression with imatinib, sunitinib and
regorafenib
por: Vincenzi, Bruno, et al.
Publicado: (2018)